Hepatitis Monthly

Published by: Kowsar

Recurrent Hepatitis in Two Iranian Children: A Novel (Q166R) Mutation in EIF2AK3 Leading to Wolcott-Rallison Syndrome

Babak Behnam 1 , 2 , 3 , Marjan Shakiba 4 , Ali Ahani 5 and Maryam Razzaghy Azar 3 , 6 , *
Authors Information
1 Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, IR Iran
2 Department of Medical Genetics and Molecular Biology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, IR Iran
3 Ali-Asghar Children Hospital, Iran University of Medical Sciences, Tehran, IR Iran
4 Department of Pediatrics, Mofid Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
5 Department of Genetics and Reproduction, Avicenna Research Center, Tehran, IR Iran
6 Endocrine and Metabolic Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: June 01, 2013, 13 (6); e10124
  • Published Online: June 9, 2013
  • Article Type: Case Report
  • Received: January 5, 2013
  • Revised: March 10, 2013
  • Accepted: April 15, 2013
  • DOI: 10.5812/hepatmon.10124

To Cite: Behnam B, Shakiba M, Ahani A, Razzaghy Azar M. Recurrent Hepatitis in Two Iranian Children: A Novel (Q166R) Mutation in EIF2AK3 Leading to Wolcott-Rallison Syndrome, Hepat Mon. 2013 ; 13(6):e10124. doi: 10.5812/hepatmon.10124.

Abstract
Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Conclusions
Acknowledgements
Footnotes
References
  • 1. Rubio-Cabezas O, Patch AM, Minton JA, Flanagan SE, Edghill EL, Hussain K, et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab. 2009; 94(11): 4162-70[DOI][PubMed]
  • 2. Wolcott CD, Rallison ML. Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr. 1972; 80(2): 292-7[PubMed]
  • 3. Biason-Lauber A, Lang-Muritano M, Vaccaro T, Schoenle EJ. Loss of kinase activity in a patient with Wolcott-Rallison syndrome caused by a novel mutation in the EIF2AK3 gene. Diabetes. 2002; 51(7): 2301-5[PubMed]
  • 4. Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis. 2010; 5: 29[DOI][PubMed]
  • 5. Thomas SE, Dalton LE, Daly ML, Malzer E, Marciniak SJ. Diabetes as a disease of endoplasmic reticulum stress. Diabetes Metab Res Rev. 2010; 26(8): 611-21[DOI][PubMed]
  • 6. al-Gazali LI, Makia S, Azzam A, Hall CM. Wolcott-Rallison syndrome. Clin Dysmorphol. 1995; 4(3): 227-33[PubMed]
  • 7. Bin-Abbas B, Shabib S, Hainau B, Al-Ashwal A. Wolcott-Rallison syndrome: clinical, radiological and histological findings in a Saudi child. Ann Saudi Med. 2001; 21(1-2): 73-4[PubMed]
  • 8. Bonthron DT, Dunlop N, Barr DG, El Sanousi AA, Al-Gazali LI. Organisation of the human PAX4 gene and its exclusion as a candidate for the Wolcott-Rallison syndrome. J Med Genet. 1998; 35(4): 288-92[PubMed]
  • 9. Stewart FJ, Carson DJ, Thomas PS, Humphreys M, Thornton C, Nevin NC. Wolcott-Rallison syndrome associated with congenital malformations and a mosaic deletion 15q 11-12. Clin Genet. 1996; 49(3): 152-5[PubMed]
  • 10. Stoss H, Pesch HJ, Pontz B, Otten A, Spranger J. Wolcott-Rallison syndrome: diabetes mellitus and spondyloepiphyseal dysplasia. Eur J Pediatr. 1982; 138(2): 120-9[PubMed]
  • 11. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet. 2000; 25(4): 406-9[DOI][PubMed]
  • 12. Senee V, Vattem KM, Delepine M, Rainbow LA, Haton C, Lecoq A, et al. Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes. 2004; 53(7): 1876-83[PubMed]
  • 13. Feng DR, Meng Y, Zhao SM, Shi HP, Wang WC, Huang SZ. [Two novel EIF2AK3 mutations in a Chinese boy with Wolcott-Rallison syndrome]. Zhonghua Er Ke Za Zhi. 2011; 49(4): 301-5[PubMed]
  • 14. Mihci E, Turkkahraman D, Ellard S, Akcurin S, Bircan I. Wolcott-Rallison syndrome due to a novel mutation (R491X) in EIF2AK3 gene. J Clin Res Pediatr Endocrinol. 2012; 4(2): 101-3[DOI][PubMed]
  • 15. Reis AF, Kannengiesser C, Jennane F, Manna TD, Cheurfa N, Oudin C, et al. Two novel mutations in the EIF2AK3 gene in children with Wolcott-Rallison syndrome. Pediatr Diabetes. 2011; 12(3 Pt 1): 187-91[DOI][PubMed]
  • 16. Sang Y, Liu M, Yang W, Yan J, Chengzhu, Ni G. A novel EIF2AK3 mutation leading to Wolcott-Rallison syndrome in a Chinese child. J Pediatr Endocrinol Metab. 2011; 24(3-4): 181-4[PubMed]
  • 17. Brickwood S, Bonthron DT, Al-Gazali LI, Piper K, Hearn T, Wilson DI, et al. Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet. 2003; 40(9): 685-9[PubMed]
  • 18. Loria P, Lonardo A, Anania F. Liver and diabetes. A vicious circle. Hepatol Res. 2013; 43(1): 51-64[DOI][PubMed]
  • 19. Balasubramanyam M, Singh LP, Rangasamy S. Molecular intricacies and the role of ER stress in diabetes. Exp Diabetes Res. 2012; 2012: 958169[DOI][PubMed]
  • 20. Chamoun Z, Vacca F, Parton RG, Gruenberg J. PNPLA3/adiponutrin functions in lipid droplet formation. Biol Cell. 2013; [DOI][PubMed]
  • 21. Zhou B, Li H, Xu L, Zang W, Wu S, Sun H. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-kappaB signaling pathway. Endocrinology. 2013; 154(3): 1055-68[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments